CA Patent

CA2539023A1 — Triamcinolone acetonide and anecortave acetate formulations for injection

Assigned to Alcon Inc · Expires 2005-04-14 · 21y expired

What this patent protects

Injectable compositions of triamcinolone acetonide or anecortave acetate are disclosed. The compositions are particularly suitable for injection into the posterior segment of the eye to treat ophthalmic diseases.

USPTO Abstract

Injectable compositions of triamcinolone acetonide or anecortave acetate are disclosed. The compositions are particularly suitable for injection into the posterior segment of the eye to treat ophthalmic diseases.

Drugs covered by this patent

triamcinolone-acetonide (TRIAMCINOLONE ACETONIDE)

Patent Metadata

Patent number: CA2539023A1
Jurisdiction: CA
Classification: —
Expires: 2005-04-14
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.